Latest Breaking News On - Robertw yeh - Page 1 : vimarsana.com

ORBITA-2: Angina Phenotype Strongly Predicts PCI Response

Drug-coated balloon shows superiority in coronary in-stent restenosis treatment

In the largest randomized clinical trial and first of its kind to date in the United States, a team led by investigators at Beth Israel Deaconess Medical Center (BIDMC) assessed the efficacy and safety of using a drug-coated balloon in patients undergoing coronary angioplasty.

Paclitaxel-Coated Balloon Effective for Coronary In-Stent Restenosis

Paclitaxel-coated balloon superior to uncoated balloon for composite end point of target lesion failure.

FDA Approves BIDMC's Coronary Drug-Coated Balloons After Trial

Paclitaxel-coated balloon effective for coronary in-stent restenosis: Study

Paclitaxel-Coated vs Uncoated Balloons in Coronary Restenosis

Paclitaxel-Coated Balloon vs Uncoated Balloon for Coronary In-Stent Restenosis

This clinical trial compares a paclitaxel-coated balloon vs an uncoated balloon in patients with in-stent restenosis undergoing percutaneous coronary interventi

BIDMC-led trial leads to FDA approval of coronary drug-coated balloons

In the largest randomized clinical trial and first of its kind to date in the United States, a team led by investigators at Beth Israel Deaconess Medical Center

BIDMC-led trial leads to FDA approval of coronary drug-coated balloons

In the largest randomized clinical trial and first of its kind to date in the United States, a team led by investigators at Beth Israel Deaconess Medical Center

Boston Scientific (BSX) Announces FDA Approval for the AGENT Drug-Coated Balloon